Last updated:
LIVE
ACCD
Accolade, Inc. · Healthcare Technology
N/A
N/A this month
VERSUS
⟷
COMPARE
TDOC
Teladoc Health, Inc. · Healthcare Technology
$9.24
+21.81% this month
Scoreboard verdict
Across AI score, momentum, valuation, upside, operating margin
ACCD
0
TDOC
0
Comparison scoreboard
MIXED SETUPAI Score
ACCD N/A
TDOC 24.1
1Y Return
ACCD N/A
TDOC +14.99%
Fwd P/E
ACCD N/A
TDOC -14.28
Target Up.
ACCD N/A
TDOC -17.17%
Op. Margin
ACCD N/A
TDOC N/A
Metrics last refreshed: 7/17/2026
Quick take
ACCD vs TDOC: Accolade vs Teladoc Stock Comparison: AI Score, Valuation, Performance and Upside
Accolade is a personalized health navigation company focused on guiding employer members through healthcare decisions using human advocates plus technology, while Teladoc is the world's largest telehealth platform covering virtual primary care, mental health via BetterHelp, and chronic disease management. Accolade emphasizes high-touch personalization; Teladoc emphasizes scale and virtual care breadth.
ACCD vs TDOC is personalized health navigation versus scale telehealth — Accolade wins if high-touch human advocacy drives superior employer outcomes and justifies premium PEPM pricing; Teladoc wins if BetterHelp stabilizes, integrated care gains traction, and telehealth becomes the default primary care channel.
Live analysis · updated 7/17/2026
ACCD and TDOC are closely matched — they split the tracked metrics evenly.
Normalized 1Y performance
ACCD
TDOC
Not enough data to chart yet.
Recent returns
ACCD
TDOC
Analyst price targets & sentiment
ACCD
Price target data unavailable
N/A
TDOC · 19 analysts
STRONG BUYHOLDSTRONG SELL
Hold (2.5/5.0)
Price target range
analyst low$5.00
analyst high$10.50
analyst mean$7.66
current price$9.24
-17.2% upside to analyst mean
Who should consider this stock?
ACCD may suit investors who:
- →want small-cap digital health exposure with a differentiated human-plus-technology health navigation model
- →believe personalized health advocacy drives better employer ROI than volume-based telehealth
- →are comfortable with unprofitability and longer employer client sales cycles
- →want exposure to mental health and complex care navigation as a growing employer benefits category
TDOC may suit investors who:
- →want the largest telehealth platform with the broadest virtual care product breadth
- →believe BetterHelp's consumer mental health platform can stabilize and return to growth
- →value Teladoc's global health system partnerships and enterprise employer relationships
- →prefer a larger, more liquid digital health company vs a small-cap navigation play
Performance & AI score
| Metric | ACCD | TDOC |
|---|---|---|
| AI score | N/A | 24.1 |
| AI rank | N/A | #3322 |
| Latest close | N/A | $9.24 |
| 1M return | N/A | +21.81% |
| 6M return | N/A | +41.58% |
| 1Y return | N/A | +14.99% |
$10,000 invested — hypothetical growth (dividends reinvested)
How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?
| Period | ACCD | TDOC |
|---|---|---|
| 1Y ago | N/A | $11.5K (+15.0%) started 2025-07-17 |
| 5Y ago | N/A | $610.76 (-93.9%) started 2021-07-19 |
| 10Y ago | N/A | $5.76K (-42.4%) started 2016-07-18 |
Hypothetical — past performance does not guarantee future results.
Valuation & upside potential
| Metric | ACCD | TDOC |
|---|---|---|
| Market cap | N/A | $1.67B |
| Trailing P/E | N/A | N/A |
| Forward P/E | N/A | -14.28 |
| Price/Sales | 1.39 | 0.66 |
| EV/Revenue | N/A | 0.79 |
| Analyst target | N/A | $7.66 |
| Target upside | N/A | -17.17% |
Growth, profitability & risk
| Metric | ACCD | TDOC |
|---|---|---|
| Revenue growth | N/A | -2.50% |
| Earnings growth | N/A | N/A |
| EPS growth | N/A | N/A |
| FCF margin | N/A | +8.28% |
| Operating margin | N/A | N/A |
| Profit margin | N/A | -6.81% |
| ROIC proxy | N/A | -12.39% |
| Return on equity | N/A | -12.39% |
| Dividend yield | N/A | 0.00% |
| Beta | -0.26 | 2.10 |
| Debt/equity | N/A | 77.68 |
| Current ratio | N/A | 2.80 |
| Quick ratio | N/A | 2.40 |
Drawdown & downside risk
Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.
1Y risk snapshot
ACCD max drawdownN/A
TDOC max drawdown52.75%
ACCD max wkly dropN/A
TDOC max wkly drop17.02%
5Y risk snapshot
ACCD max drawdownN/A
TDOC max drawdown97.14%
ACCD max wkly dropN/A
TDOC max wkly drop43.25%
10Y risk snapshot
ACCD max drawdownN/A
TDOC max drawdown98.48%
ACCD max wkly dropN/A
TDOC max wkly drop43.25%
Performance metrics by period
| Period | Metric | ACCD | TDOC |
|---|---|---|---|
| 1Y | Growth | N/A | +14.99% |
| CAGR | N/A | +15.00% | |
| Sharpe ratio | N/A | 0.45 | |
| Max drawdown | N/A | 52.75% | |
| Max daily drop | N/A | 9.60% | |
| Max wkly drop | N/A | 17.02% | |
| 5Y | Growth | N/A | -93.89% |
| CAGR | N/A | -42.87% | |
| Sharpe ratio | N/A | -0.62 | |
| Max drawdown | N/A | 97.14% | |
| Max daily drop | N/A | 40.15% | |
| Max wkly drop | N/A | 43.25% | |
| 10Y | Growth | N/A | -42.40% |
| CAGR | N/A | -5.37% | |
| Sharpe ratio | N/A | 0.14 | |
| Max drawdown | N/A | 98.48% | |
| Max daily drop | N/A | 40.15% | |
| Max wkly drop | N/A | 43.25% |
Business comparison
| Category | ACCD | TDOC |
|---|---|---|
| Company | Accolade, Inc. | Teladoc Health, Inc. |
| Sector | Healthcare Technology | Healthcare Technology |
| Industry | N/A | N/A |
| Core business | Personalized health navigation and advocacy platform sold to employers and health plans. Accolade combines human health assistants with technology to guide members through complex healthcare decisions, reducing cost and improving outcomes. | The world's largest telehealth platform, offering virtual primary care, mental health (BetterHelp), chronic disease management, and specialty virtual care. Teladoc serves employers, health plans, and hospitals globally. |
| Investor focus | Revenue per member (PEPM), employer client retention, expansion into mental health and complex care, and path to profitability. | BetterHelp mental health revenue and margin recovery, integrated care member growth, chronic condition management program enrollment, and path to EBITDA profitability. |
ACCD strengths
- →Personalized human-plus-technology health navigation model drives high member engagement vs purely virtual care alternatives
- →Strong employer client retention once integrated into benefits programs creates durable recurring revenue
- →PlushCare acquisition expanded Accolade into direct primary and mental health virtual care
TDOC strengths
- →Teladoc is the global telehealth market leader with the largest network of clinicians and most diversified virtual care products
- →BetterHelp is one of the largest consumer mental health platforms globally by user base
- →Multi-product platform with whole-person virtual care (primary, mental, chronic condition) creates employer cross-sell opportunities
Risks to watch — ACCD
- →Accolade remains unprofitable with significant EBITDA losses as it scales its human advocacy workforce
- →Employer HR decision cycles are long — new client ramp takes 12–18 months before revenue is recognized
- →Competition from larger benefits platforms (Teladoc, CVS Health) could commoditize health navigation
Risks to watch — TDOC
- →Teladoc took massive goodwill impairment charges on the Livongo acquisition — the $18.5B acquisition has been deeply value-destructive
- →BetterHelp faces increasing competition from mental health startups, health plans, and employer-sponsored programs at lower price points
- →Path to sustained EBITDA profitability requires significant margin improvement from current levels
Frequently asked questions
Free public comparison
Want deeper AI forecasts?
This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.
Related comparisons
More comparisons
Browse all 1,000 comparisons →